Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 11/20 | 0.51 |
| ▸ | CACNA1F | O60840 | 6/20 | 0.50 |
| ▸ | CACNA1D | Q01668 | 6/20 | 0.50 |
| ▸ | CACNA1S | Q13698 | 6/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 6/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11254571 | 0.84 | CACNA1B (0.47) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11257667 | 0.80 | ADORA3 (0.57) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11256475 | 0.79 | SLC6A3 (0.47) | CACNA1B | |
| SCHEMBL11261733 | 0.79 | CACNA1F (0.50) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11259253 | 0.79 | SLC6A3 (0.46) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11392503 | 0.77 | CACNA1B (0.53) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11389848 | 0.76 | CACNA1B (0.50) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL27412226 | 0.76 | CACNA1B (0.61) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL11262288 | 0.75 | CACNA1F (0.50) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7047706 | 0.74 | CACNA1F (0.66) | CACNA1BCACNA1FCACNA1DCACNA1SCACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4360520-A | 1,4-Dihydropyridazine compounds, and their medicinal use | BAYER AKTIENGESELLSCHAFT (DE) | 1982-11-23 | — | — | US | disclosed |